Rapport Therapeutics Inc....

NASDAQ: RAPP · Real-Time Price · USD
14.58
-0.13 (-0.85%)
At close: Aug 18, 2025, 3:59 PM
14.88
2.06%
After-hours: Aug 18, 2025, 07:38 PM EDT

Rapport Therapeutics Common Stock Revenue

Rapport Therapeutics Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Rapport Therapeutics Common Stock generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
69
Market Cap
532.14M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 0 n/a
Dec 31, 2023 0 n/a
Dec 31, 2022 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.